Results 201 to 210 of about 292,062 (298)

Uncovering the Role of Intrinsic Magnetic Order in Oxygen Evolution Reaction Activity With Operando Spectroscopy

open access: yesAdvanced Energy Materials, EarlyView.
Operando magnetic spectroscopy provides insight into how intrinsic magnetic order modulates the oxygen evolution reaction on La0.67Sr${\rm La}_{0.67}{\rm Sr}$0.33MnO$_{0.33}{\rm MnO}$3$_3$ thin films. Temperature‐dependent operando FMR and ambient‐pressure XMCD suggest a correlation between activity and the emergence of ferromagnetic regions near and ...
Emma van der Minne   +9 more
wiley   +1 more source

On the Importance of Electronic Symmetry for Triplet State Delocalization. [PDF]

open access: yesJ Am Chem Soc, 2017
Richert S   +5 more
europepmc   +1 more source

Recent Advances in Nano‐Microstructured Catalysts for Electrochemical Seawater Electrocatalysis

open access: yesAdvanced Energy Materials, EarlyView.
This review highlights advances in nano‐ and microstructured catalysts for electrochemical seawater conversion. It elucidates design principles, mechanistic understanding, and machine‐learning‐assisted discovery, and outlines key challenges and future opportunities toward efficient, selective, and durable seawater electrocatalysis.
Xiaodong Shao   +5 more
wiley   +1 more source

Dual Impact of Long‐Lived Localized Carriers Induced by Restricted Hole Transfer in Organic Photovoltaics and Photocatalytic Hydrogen Evolution

open access: yesAdvanced Energy Materials, EarlyView.
This work clarifies why organic semiconductors perform differently in photovoltaic devices and photocatalytic nanoparticles. By examining D18:Y5 and PM6:Y6 systems, we show how aggregation, exciton lifetime, and interfacial charge transfer behavior govern energy‐conversion pathways.
Gayoung Ham   +14 more
wiley   +1 more source

Essential Updates 2024–2025: Surgical Strategy for Esophageal Cancer Toward a New Paradigm in the Era of Immunotherapy and Personalization

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
This review summarizes key advances from 2024 to 2025 that are reshaping esophageal cancer surgery toward a strategy‐oriented, personalized paradigm through the integration of immunotherapy, population aging, and intelligent technologies. Adjuvant nivolumab after neoadjuvant chemoradiotherapy remains the only perioperative approach with durable benefit,
Shuichiro Oya   +2 more
wiley   +1 more source

Management Strategies for Disappearing Colorectal Liver Metastases After Systemic Chemotherapy: Long‐Term Outcomes and Preoperative Prediction of ‘True Complete Response’

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
ABSTRACT Background Determining whether to resect disappearing liver metastases (DLMs) after chemotherapy for colorectal liver metastases (CRLMs) remains challenging. Methods Patients who underwent hepatectomy after systemic chemotherapy for initially unresectable CRLMs were reviewed. True complete response (CR) was defined as either resected DLMs with
Taihei Soma   +9 more
wiley   +1 more source

Survival Outcomes of Gemcitabine–Cisplatin–S‐1 Versus Gemcitabine–Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a Focus on Conversion Surgery

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
In this multicenter retrospective study conducted by the Biliary Tract Club, we compared survival outcomes between gemcitabine–cisplatin–S‐1 (GCS) and gemcitabine–cisplatin (GC) in patients with unresectable biliary tract cancer, with a particular focus on conversion surgery. GCS was associated with longer overall and progression‐free survival compared
Hisashi Kosaka   +27 more
wiley   +1 more source

Potential Survival Benefit of Neoadjuvant Docetaxel, Cisplatin and 5‐Fluorouracil Therapy in Patients With Esophageal Squamous Cell Carcinoma With Multiple Lymph Node Metastases: A Single‐Institute Propensity Score Analysis

open access: yesAnnals of Gastroenterological Surgery, EarlyView.
Although neoadjuvant chemotherapy with fluorouracil, cisplatin, and docetaxel (NAC‐DCF) is the current standard neoadjuvant regimen for esophageal squamous cell carcinoma, its substantial toxicity underscores the need to identify patients who derive the greatest benefit.
Eiji Higaki   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy